Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH). An N-terminal trans-3-hexenoyl modification improves resistance to enzymatic degradation while preserving activity at the GHRH receptor.
Research applications include GHRH-receptor binding and activation, peptide-stability comparisons, downstream growth-hormone-axis signaling, and controlled in vitro or preclinical studies of endocrine and metabolic responses. These uses describe experimental pathways and do not establish suitability for any clinical application.
Supplied as lyophilized research material in 10 mg and 20 mg formats. The molecular characteristics refer to tesamorelin free base; batch documentation should be used to confirm measured identity and purity.
Research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, cosmetic, food, drug, or consumption purposes.